PharmaVoice

Pharma Tech

European big pharma unites amid ‘ringing alarm bells’ of continent’s dominance

All the chairs of Europe’s big pharma companies have written a public letter asserting that a shift in strategy is needed to close the gap to international rivals.

Read Full Article

Pharma Tech

How China’s rise as a biopharma innovation hub is reshaping global dealmaking strategies

GlobalData briefing: China biopharma drives global licensing growth, platform acquisitions, amid tightening US scrutiny.

Read Full Article

Pharma Tech

BoomRay and Novartis sign $900m deal for radioligand therapy

BoomRay Pharmaceuticals and Novartis have signed an exclusive worldwide licence deal for an undisclosed preclinical RLT asset in a deal worth up to $900m.

Read Full Article

Express Pharma

Treating hair loss as a health issue, not just a haircare concern

Traya has treated hair loss as a health issue rather than simply a cosmetic concern. How has this approach shaped the way you have built the business and developed your offerings? We operate very differently from a conventional haircare brand. In most cases, consumers either buy a product off the shelf, such as an oil […] The post Treating hair loss as a health issue, not just a haircare concern appeared first on Express Pharma.

Read Full Article

Pharma Tech

Boehringer and Envisagenics to develop precision cancer therapies in $1bn deal

Boehringer Ingelheim and Envisagenics have entered into a research collaboration and option agreement aimed at validating tumour-specific targets for the development of precision therapies in solid tumours.

Read Full Article

Featured promotional

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

Pharma Tech

Sep 23, 2026, 1:52 PM

European big pharma unites amid ‘ringing alarm bells’ of continent’s dominance

All the chairs of Europe’s big pharma companies have written a public letter asserting that a shift in strategy is needed to close the gap to international rivals.

European big pharma unites amid ‘ringing alarm bells’ of continent’s dominance

How China’s rise as a biopharma innovation hub is reshaping global dealmaking strategies

BoomRay and Novartis sign $900m deal for radioligand therapy

Treating hair loss as a health issue, not just a haircare concern

Boehringer and Envisagenics to develop precision cancer therapies in $1bn deal

Featured promotional

Jeplus.in

Latest stories

European big pharma unites amid ‘ringing alarm bells’ of continent’s dominance

Genentech Reports Topline P-II (CT-388-104) Trial Data on Enicepatide in T2D and Overweight or Obesity

How China’s rise as a biopharma innovation hub is reshaping global dealmaking strategies

Syneos Health houses global tech centre in Hyderabad

The EC Approves AstraZeneca’s Trixeo Aerosphere for Uncontrolled Asthma

Otsuka and Ionis Report P-III (FUSION) Trial Results for Ulefnersen in FUS-ALS

Latest industry coverage

Teva Pharmaceutical Industries Ltd. to Report Third Quarter 2026 Financial Results on November 3, 2026 - Quiver Quantitative

ArcaScience brings an AI lens to drug benefit-risk tradeoffs - FirstWord

Cellares, SNUH Partner on Cell Therapy Manufacturing - Contract Pharma

Innocan Pharma Announces First Tranche Closing of Private Placement of Units - PR Newswire

Lilly Breaks Ground on $6.5 Billion Houston Manufacturing Plant - CHEManager

AustinPx KinetiSol Earns FDA AMT Designation - Contract Pharma

Astoriom Acquires Roylance Stability Storage and Roylance Scientific - Contract Pharma

Consumers look to salvage suit over Big Pharma price-fixing scheme - Courthouse News

Carbohydrate Sources Market To 2035: Biologics Demand Drives Growth - News and Statistics - IndexBox

Featured promotions

Jeplus.in